Topic
Biosimilars
856 published works
Health Industry Washington Watch
FDA User Fee Program for Biosimilar and Interchangeable Biological Product Applications
The Food and Drug Administration (FDA) published a notice on May 10, 2011 seeking comments on its upcoming user fee program for biosimilar and interchangeable biological product (351(k)) applications. The…
Health Industry Washington Watch
FDA Seeks Stakeholder Participation in ACA Biosimilars User Fee Meetings
On December 8, 2010, the Food and Drug Administration (FDA) published a notice requesting that stakeholders - particularly patient and consumer advocacy groups, health care professionals, and scientific and academic experts…
Health Care and Life Sciences
FDA Announces Much Anticipated Public Hearing on Biosimilars
By Deborah M. Shelton Having had the opportunity to analyze the biosimilars provisions of the new health care law enacted this past March, stakeholders have at long last the chance…
Life Sciences Legal Update
FDA to Hold Public Meeting on ACA Biosimilars Pathway – November 2-3, 2010
Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which…
Health Industry Washington Watch
FDA to Hold Public Meeting on ACA Biosimilars Pathway – November 2-3, 2010
Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which…
Chicago IP Litigation
Tribune on Patents
The Chicago Tribune has had a few IP-related articles this week. First, the Tribune reported - click here for the story -- that the House is about to take up…